Table 1 Characteristics of the included studies.

From: Tranexamic acid in ear surgery: enhancing surgical field visibility and reducing bleeding—a systematic review and meta analysis

Study

Sample size

Age

Male rate (%)

Country

Study design

Intervention

Control

Outcomes

Zhang et al.17

56

45.6 ± 11.9

42.8

China

Randomized double-blinded controlled study

TXA (tranexamic acid) group (1 g diluted to 20 ml normal saline)

20 ml normal saline

Bleeding score, Duration of surgery (minutes), Surgeon satisfaction

Ziaei et al.18

73

33.0

55.1

Iran

Randomized double-blinded controlled study

Tranexamic acid (10 mg/kg)

Normal saline with equal volume

Duration of surgery (minutes), amount of bleeding (ml), MAP (mmHg)

Das et al.16

50

28.5

64.0

India

Randomized double-blinded controlled study

Intravenous tranexamic acid bolus (10 mg/kg) half an hour

Normal saline with equal volume

Bleeding score, Duration of surgery (minutes), MAP (mmHg)

Aghadavoudi et al.15

69

33.1

58.1

Iran

Randomized double-blinded controlled study

Tranexamic acid (10 mg/kg)

No injection

Surgeon satisfaction, amount of bleeding (ml), MAP (mmHg)

  1. MAP mean arterial pressure.